Please feel free to contact us for a quote and further discussion with our scientists.
Datasheets
| Specifications | |
|---|---|
| Product Description | BRD9-binding moiety 1 hydrochloride is a compound that binds to BRD9, and used for inhibiting BRD9 activity, based on PROTAC® pathway. |
| Molecular Formula | C23H26ClN3O7S2 |
| Molecular Weight (Da) | 556.05 |
| Chemical Name | (3-Chloro-5-methylsulfonylphenyl)methyl 2-(3-sulfamoylbenzoyl)-2,7-diazaspiro[3.5]nonane-7-carboxylate |
| Chemical Structure |  |
| Purity | 98.2% |
| Solubility | 20.83 mg/mL (37.46 mM) in DMSO |
| Size | 5 mg |
| Physical State | Powder |
| Storage | The power can be stored at 4 °C for 2 years or at -20 °C for 3 years. |
| Target Information | |
|---|---|
| Target Name | Bromodomain-containing protein 9 (BRD9) |
| Alternative Names | Rhabdomyosarcoma antigen MU-RMS-40.8 |
| Introduction | BRD9 is the component of SWI/SNF chromatin remodeling subcomplex GBAF that carries out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner. |
| Gene ID | 65980 |
| UniProt ID | Q9H8M2 |
| Related Disease | BRD9-related disease |
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us